Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis.

CONCLUSIONS: There was no significant difference in the occurrence of any or major breast-related complications between the two different fractionation regimens, even in patients with mastectomy. Hypofractionated RT may be used comparable to conventional fractionated RT in terms of breast-related complications in reconstructed breast cancer patients. The prospective randomized trial would be necessary to clarify this issue.
PMID: 33316582 [PubMed - as supplied by publisher]

Source: Breast - December 1, 2020 Category: Cancer & Oncology Authors: Kim DY, Park E, Heo CY, Jin US, Kim EK, Han W, Shin KH, Kim IA Tags: Breast Source Type: research